Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-24

FDA Approved: CARVEDILOL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for carvedilol by Sandoz Inc. This is a supplemental approval for a generic carvedilol product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)